Vaccines based on targeting antigen to DCIR expressed an antigen-presenting cells

Details for Australian Patent Application No. 2008214032 (hide)

Owner Baylor Research Institute

Inventors Banchereau, Jacques F.; Zurawski, Gerald

Agent Pizzeys

Pub. Number AU-B-2008214032

PCT Pub. Number WO2008/097866

Priority 60/888,032 02.02.07 US

Filing date 1 February 2008

Wipo publication date 14 August 2008

Acceptance publication date 28 June 2012

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/097866 Priority application(s): WO2008/097866

28 June 2012 Application Accepted

  Published as AU-B-2008214032

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008214036-Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (DCASGPR)

2008214029-Methods for producing yeast-based vaccines